Pharmaceuticals: How Do We Ensure Rapid Response?

Dec. 7, 2020
The key lies in a strong, proactive regulatory strategy.

Can you have a regulatory strategy in place to accelerate drug development — without getting slowed down by compliance considerations?

The COVID-19 pandemic has created an inflection point between the need for speed and the need to protect patient safety. For this balancing act to succeed, drug developers need a detailed, forward-thinking regulatory strategy. With a strategy in place — and expert guidance to help put it into action — you will be able to improve response time in the face of unexpected health crises.

The lessons we learn today will reshape the pharma industry’s capability to respond more quickly and more safely. Building compliance strategy into ongoing operations will be essential to maximizing that capability. There are three components to a rapid, compliant response...

Read the rest of this article from our sister publication Pharma Manufacturing.

Sponsored Recommendations

Keys to Improving Safety in Chemical Processes (PDF)

Many facilities handle dangerous processes and products on a daily basis. Keeping everything under control demands well-trained people working with the best equipment.

Get Hands-On Training in Emerson's Interactive Plant Environment

Enhance the training experience and increase retention by training hands-on in Emerson's Interactive Plant Environment. Build skills here so you have them where and when it matters...

Managing and Reducing Methane Emission in Upstream Oil & Gas

Measurement Instrumentation for reducing emissions, improving efficiency and ensuring safety.

Micro Motion 4700 Coriolis Configurable Inputs and Outputs Transmitter

The Micro Motion 4700 Coriolis Transmitter offers a compact C1D1 (Zone 1) housing. Bluetooth and Smart Meter Verification are available.